Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Socs2
REST API REST API
Rattus norvegicus
Socs2 is differentially expressed in 64 experiments: 34 organism parts: hippocampus, kidney, ... (32 more);, 3 disease states: breast carcinoma, moderate spinal cord injury, ... (1 more);, 6 cell types 63 compound treatments 2 biosource types and 15 other conditions.
Synonyms Cish2, Socs-2
Orthologs Q4H2S6_CIOIN (Ciona intestinalis)   Q8AYA6_CHICK (Gallus gallus)   socs2 (Danio rerio)   Gm9847 (Mus musculus)   SOCS2 (Homo sapiens)   Socs2 (Mus musculus)   Socs44A (Drosophila melanogaster)   socs2 (Xenopus tropicalis)   (Compare orthologs)
Gene Ontology Term insulin-like growth factor receptor binding, protein binding, negative regulation of signal transduction, molecular_function, aging, cellular_component, regulation of growth, response to peptide hormone stimulus, growth hormone receptor signaling pathway, response to estradiol stimulus, cellular response to hormone stimulus, intracellular signal transduction
UniProt Accession O88582, Q9QX77
InterPro Term SH2 motif, SOCS protein, C-terminal
Search EB-eye ENSRNOG00000008965
Show more properties
Experimental Factors
organism part

studied in E-GEOD-19830, E-GEOD-2354, E-AFMX-7, E-GEOD-2880, E-GEOD-142, ... (15 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

cell type

studied in E-GEOD-2499, E-TABM-130, E-GEOD-2032, E-TABM-432

Factor Value U/D Experiments
myoctye
1
E-GEOD-2032
Sertoli cell
2
1
E-TABM-432
spermatocyte
1
1
E-TABM-130
spermatid
1
1
E-TABM-130
spermatogonium
2
1
E-TABM-432
multipotent neural progenitor cell
1
E-GEOD-2499


disease state

studied in E-GEOD-1872, E-GEOD-464

Factor Value U/D Experiments
normal
25
1
E-GEOD-1872
moderate spinal cord injury
1
1
E-GEOD-464
breast carcinoma
1
E-GEOD-1872


Compound treatment

studied in E-GEOD-7002, E-MEXP-1421, E-GEOD-1872, E-MEXP-1169, E-MTAB-797, ... (8 experiments)

Factor Value U/D Experiments
17a-ethynylestradiol 10 micrograms per kilogram
1
E-MEXP-999
carboplatin 3000 micromolar
1
E-MTAB-797
disulfiram 12 micromolar
1
E-MTAB-797
formaldehyde 2 parts per million
1
E-GEOD-7002
disulfiram 2.4 micromolar
1
E-MTAB-797
dantrolene 0.4 micromolar
1
E-MTAB-797
57 more value(s).


biosource type

studied in E-MEXP-1069

Factor Value U/D Experiments
fresh_sample
1
E-MEXP-1069
frozen_sample
1
E-MEXP-1069


Clinical info

studied in E-AFMX-10

Factor Value U/D Experiments
biopsy 5
1
E-AFMX-10


clinical treatment
studied in E-GEOD-738, E-GEOD-1616

cohort
studied in E-GEOD-20388

developmental stage
studied in E-GEOD-4236, E-MEXP-570, E-GEOD-20245

genetic modification
studied in E-GEOD-6428

growth condition
studied in E-GEOD-7041, E-MEXP-2863, E-MEXP-1421

material type
studied in E-GEOD-467

protocol
studied in E-GEOD-20895

protocol type
studied in E-GEOD-1139, E-GEOD-1616, E-MEXP-1565

replicate
studied in E-GEOD-4192

sampling time point
studied in E-MTAB-797

strain or line
studied in E-TABM-197, E-MTAB-322, E-TABM-457, E-AFMX-7, E-MTAB-323, ... (7 experiments)

temperature
studied in E-MEXP-1069

tissue region
studied in E-GEOD-21681

treatment
studied in E-GEOD-7002, E-GEOD-19909

Processing time: 1.241 secs.
 
Gene Expression Atlas 2.0.13- 4/23/12 11:55:46 AM